The best indicator for C.H. Robinson (CHRW)
We backtested 20 indicators across daily, weekly and hourly charts on real C.H. Robinson (CHRW) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the weekly chart, this is the strongest risk-adjusted edge we found for C.H. Robinson (CHRW) over ~28.8 years — trailing buy-and-hold by 5.9% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Weekly | 9.1% | 0.72 | -22.5% | 89.3% | 28 | -5.9% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 12.5% | 0.64 | -27.6% | 76.0% | 121 | -2.5% |
| 3 | Stochastic ✓ | Daily | 10.8% | 0.61 | -33.9% | 70.0% | 140 | -4.2% |
| 4 | Holy Grail Confluence ✓ | Daily | 8.9% | 0.58 | -39.0% | 83.3% | 42 | -6.1% |
| 5 | Stochastic ✓ | Weekly | 7.0% | 0.55 | -28.5% | 81.5% | 27 | -8.0% |
| 6 | CCI ✓ | Daily | 9.7% | 0.54 | -39.9% | 76.9% | 147 | -5.3% |
| 7 | CCI ✓ | Weekly | 7.7% | 0.53 | -35.2% | 87.1% | 31 | -7.2% |
| 8 | Williams %R ✓ | Daily | 9.3% | 0.52 | -37.2% | 69.7% | 178 | -5.7% |
| 9 | Money Flow Index ✓ | Daily | 9.0% | 0.5 | -42.3% | 88.0% | 25 | -6.0% |
| 10 | Williams %R ✓ | Weekly | 7.3% | 0.5 | -28.6% | 78.9% | 38 | -7.7% |
| 11 | Bollinger Mean-Reversion ✓ | Daily | 7.0% | 0.49 | -21.3% | 68.9% | 106 | -8.0% |
| 12 | EMA 20/50 Cross ✓ | Weekly | 9.1% | 0.46 | -39.3% | 50.0% | 16 | -5.9% |
| 13 | WaveTrend (8/6/4) ✓ | Weekly | 6.8% | 0.46 | -32.0% | 78.3% | 23 | -8.2% |
| 14 | RSI Mean-Reversion ✓ | Daily | 5.0% | 0.44 | -32.7% | 70.3% | 37 | -10.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For C.H. Robinson (CHRW), Bollinger Mean-Reversion on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.